VEGFA and fibrosis: Moreover, compared with bleomycin induced model, administration of RC28-E induced a significant down-regulation of VEGF, FGF, and TGF-β in fibrosis lungs in a concentration-dependent manner, and better suppression of RC28-E than a mono-target antagonist treatment (RC28-C1 or RC28-C2).